A sensitive HPLC method was developed and validated for the estimation of related substances in Brexpiprazole in drug Product. The developed method is found to be specific, reproducible, and stability indicating. Kromasil100-5 C18 (150x4.6mm), 5μ column was used and mobile phase consisted of mixture of phosphate buffer of p H 5.2 and ACN in gradient program is used at a flow rate of 1.0mL/min at a wave length of 215 nm. The detector linearity was established from concentrations ranging from LOQ-150% of specification level with a correlation co-efficient of 0.999. The method was also validated for specificity, LOD, LOQ, accuracy, robustness, precision. The method is proved to be robust with respect to change in flow rate, pH, organic phase composition and column temperature. The proposed method is found to be sensitive, precise, rapid, reproducible, and offers good column life. 
INTRODUCTION 1-3
Brexpiprazole (7-{4-[4-(1-benzothiophen-4-yl] butoxy} quinolin-2(1H)-one) is serotonin dopamine activity modulator with partial agonist activityat serotonin -1A -(5-HT1A) and D2 and D3 receptors, combined with potent antagonist effect on 5-HT2A, α1B, and α2C adrenergic receptors. Brexpiprazole is used in the treatment of Alzheimer's disease, hyperactivity disorder, Post-traumatic stress disorder, treatment of bipolar disorder, Adjunctive Treatment of Major Depressive Disorder, and Schizophrenia. Brexpiprazole is more potent drug than the other class of antipsychotic drugs like aripiprazole, therefore lower dose used. Brexpiprazole is higher affinity for serotonin 5HT1A receptors. Aripiprazole also higher affinity for serotonin 5HT1A receptors but lesser extent compare to Brexpiprazole.
The amount of active pharmaceutical substance is more important for activity and potency of drug. Stability indicating related substances method is a quantitative analytical method based on the structural and chemical properties of each active ingredient of a drug product. In the present work, intrinsic stability of the drug Brexpiprazole was found and a selective, precise and accurate RP-HPLC method was developed for Stability indicating Related Substances of Brexpiprazole.
Figure 1: Chemical structure of Brexpiprazole
In the present work, a simple, rapid, precise and sensitive reverse phase HPLC method was developed and validated for the estimation of Brexpiprazolein pharmaceutical tablet dosage form. 
Equipment:
Waters e2695 gradient system with Empower-2 software and 2996 module Photo Diode Array detectors equipped with a quaternary solvent delivery pump, automatic sample injector and column thermostat was used for the analysis.
Chromatographic conditions:
Column : Kromasil 100 5 C-18 (150×46mm,5µ) 
Preparation of the Brexpiprazolestandard solution
Weigh and transfer accurately about 42 mg of Brexpiprazole standard into a 200 ml clean and dry volumetric flask. Add about 120 ml of methanol and sonicate to dissolve completely for about 15-20 minutes. Dilute to volume with diluent-1 and mix well. Transfer 4 ml of above solution into 100 ml clean, dry volumetric flask, dilute to volume with diluent-2 and mix well. Further dilute 3ml above solution to 100 ml clean, dry volumetric with diluent-2 and mix well. Filter through PVDF Millipore or suitable by discarding about 5ml of initial solution.
Preparation of sample solution
Transfer 10 tablets into a 100 ml clean and dry volumetric flask, add about 10ml of diluent-1 and sonicate for about 10 minutes until all tablets completely disperse, add about 70 mL methanol and sonicate at room temperature for about 45 minutes with every 5 minutes intermittent shaking. Make up to the volume with diluent-1 and mix. Centrifuge the solutions at 5000rpm for 10 minutes. Filter the Supernatant solution through finer porosity membrane filter (PVDF-0.45µ) by discarding about 5 ml initial solution
Preparation of placebo solution
Weigh and Transfer the placebo powder equivalent to about 2.5mg of Brexpiprazole into a 100 ml clean and dry volumetric flask, add about 10ml of diluent-1 and sonicate for about 10 minutes, add about 70 mL methanol and sonicate at room temperature for about 45 minutes with every 5 minutes intermittent shaking. Make up to the volume with diluent-1 and mix. Centrifuge the solutions at 5000rpm for 10 minutes. Filter the Supernatant solution through finer porosity membrane filter (PVDF-0.45µ) by discarding about 5 ml initial solution.
Method Development and Validation of HPLC
The proposed analytical method was validated according to ICH guidelines (Q2B) with respect to certain parameters such as system suitability, specificity, linearity, accuracy, precision, robustness and ruggedness.
Specificity
The specificity was carried out to determine whether there is any interference of any impurities in retention time of analytical peak 9 . The specificity of the method was determined by observing the interference of any of the possible impurities and excipients.
Linearity
The linearity of an analytical procedure is its ability (within a given range) to obtain test results which are directly proportional to the concentration ( 
Precision
The precision of an analytical procedure expresses the closeness of agreement (degree of scatter) between a series of measurements obtained from multiple sampling of the same homogeneous sample under the prescribed conditions. Precision may be considered at three levels: repeatability (same day), intermediate precision (Intraday-Three different day, Intraday-different time interval on the same day), and reproducibility (different lab). Precision was carried out by injecting six replicates at the 100% level. The RSD of the peak areas of each impurity was calculated.
Limit of Detection and quantification
The LOD is defined as the lowest amount of analyte in a sample, but not necessarily quantify as an exact value and the LOQ was defined as the lowest amount of analyte in a sample determined with suitable precision and accuracy . The LOD and LOQ for Brexpiprazole was determined as a S/N ratio of 3:1 and 10:1 respectively by injecting a series of dilute solution with known concentration.
Robustness
To determine the robustness, three parameters were varied: flow rate, pH and percent composition of the organic modifier. Deliberate changes in the following parameters which affect area of Brexpiprazole and system suitability parameters were studied.
1) Change in % organic phase of mobile phase by ± 5.0%
2) Change in pH of buffer of water by ± 10% of set pH 3) Change in the flow rate of the mobile phase by ± 10% of the original flow rate
System Suitability
System suitability test was used to verify whether the system was adequate for the analysis to be performed; it was an integral part of chromatographic method development. The system suitability parameters were evaluated for the developed method by calculating the RSD values of retention 
RESULTS AND DISCUSSIONS
The present investigation reported is a new RP-HPLC method development and validation of estimation of Brexpiprazole. In order to get the optimized RP-HPLC method, various mobile phases and columns were used.
From several trials final method is optimized with the following conditions:
Linearity
A series of solutions were prepared using Brexpiprazole standard at concentration levels from 1% to 150% of standard concentration level and each solution was injected into HPLC. Hence the results were obtained within the limit. 
System suitability
System suitability test was used to verify whether the system was adequate for the analysis to be performed; it was an integral part of chromatographic method development. The system suitability parameters were evaluated for the developed method by calculating the RSD values of retention time, peak area, asymmetry, and theoretical plates of Six standard replicates. 
Accuracy of the proposed HPLC method
Sample Solutions were prepared in triplicate using equivalent amount of placebo present in Brexpiprazole Tablets Spiked with Known amount of Brexpiprazole drug substance at levels LOQ, 50%,100% and 150% of specification as per test method and injected each solution into HPLC. 
Precision
The precision of the method was ascertained from determinations of peak areas of six replicates of sample solution and one Standard.
System Precision
Standard Solutions was prepared as per test method and injected six times into HPLC as per methodology. 
Method Precision
Six Sample Solutions was prepared as per test method and injected into HPLC as per methodology. 
CONCLUSION
The developed and validated stability indicating RP-HPLC Related Substances method is specific, Sensitive and robust.
The method found to be advantageous and simple by using Gradient elution mode. All the analytical data for all method validation parameters tested and found out to be satisfactory. The developed method can suitably use by quality control department to determine the Related substances in commercial and stability test samples of Brexpiprazole Tablets.
